Page last updated: 2024-08-23

daunorubicin and Desmoplastic Small Cell Tumor

daunorubicin has been researched along with Desmoplastic Small Cell Tumor in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Algar, E; Ashley, DM; Bandopadhayay, P; Ekert, PG; Gordon, L; Jabbour, AM; Popovski, D; Riffkin, C; Rigby, L; Salmanidis, M; Thomas, DM; Watkins, DN1

Other Studies

1 other study(ies) available for daunorubicin and Desmoplastic Small Cell Tumor

ArticleYear
The oncogenic properties of EWS/WT1 of desmoplastic small round cell tumors are unmasked by loss of p53 in murine embryonic fibroblasts.
    BMC cancer, 2013, Dec-09, Volume: 13

    Topics: Animals; Apoptosis; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Proliferation; Cell Survival; Cells, Cultured; Daunorubicin; Desmoplastic Small Round Cell Tumor; DNA Copy Number Variations; Drug Resistance, Neoplasm; Fibroblasts; Humans; Mice; Mice, Transgenic; Nuclear Proteins; Oncogene Proteins, Fusion; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Radiation Tolerance; Transcriptome; Tumor Suppressor Protein p53; Wnt Signaling Pathway

2013